Search results
Results From The WOW.Com Content Network
In the United States, a cooperative research and development agreement (CRADA or CRDA) is an agreement between a government agency and another government agency, a private company, non-profit, or university to work together on research and development.
CEL-SCI Announces Cooperative Research and Development Agreement (CRADA) for Multikine with US Navy VIENNA, Va.--(BUSINESS WIRE)-- CEL-SCI Corporation (NYSE MKT:CVM) today announced that it has ...
The work on this standard began in July 2002—subsequently, a U.S. Food and Drug Administration pilot project was initiated in July 2003 through a Cooperative Research and Development Agreement (CRADA). Feedback from this pilot and continuous efforts to more closely align this implementation with the SDTM for human clinical trials led to ...
Federal Technology Transfer Act of 1986; Long title: An Act to amend the Stevenson-Wydler Technology Innovation Act of 1980 to promote technology transfer by authorizing Government-operated laboratories to enter into cooperative research agreements and by establishing a Federal Laboratory Consortium for Technology Transfer within the National Science Foundation, and for other purposes.
Also in 2010, Biomatrica signed a collaborative research and development agreement (CRADA) with United States Army Medical Research Institute for Infectious Diseases (USAMRIID) to develop and test new technologies for ambient temperature stabilization of clinical and biological samples. [11]
A research and development (R&D) Agreement is an agreement, usually a contract, between two entities to conduct research and development. “Research and Development Agreement is a systematic activity combining both basic and applied research , and aimed at discovering solutions to problems or creating new goods and knowledge.” [ 1 ]
In January, it was announced that Kite Pharma has entered into a Cooperative Research and Development Agreement (CRADA) with the NCI for the research and clinical development of a fully human anti-CD19 chimeric antigen receptor (CAR) product candidate for the treatment of B-cell lymphomas and leukemia. [29]
In February 2021, USUHS and HJF entered into a Cooperative Research and Development Agreement (CRADA) with OYE Therapeutics, a Purdue University affiliated company “working to reduce the mortality and morbidity resulting from injuries on the battlefield through the development of new life-saving strategies.” [8]